// App-Quantinova.ai

: Safety and Efficacy of a Novel Basal-Bolus Insulin Delivery Device (IDD) in Adults with T2D Using Rapid-Acting or Regular Human Insulin

Researchers

Presenter

  • RONNIE ARONSON

Principal Investigators

  • EDWARD T. MAHONEY

  • DRILON SALIU

  • LEYA BERGQUIST

Medical Centers

  • N/A

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Hemoglobin A1c

  • Insulin

Drug/Treatment

  • Recombinant insulin

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

  • Open Label

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved